Consumers' Attitudes Toward Generic Drugs

Podulka, Melanie; Krautkramer, Kathleen; Amerson, Dawn; Phillips, Bryan T.; Dolinsky, Donna

doi:10.3109/j058v04n01_06

Cited by 14 publications

(9 citation statements)

References 2 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Any sur vey of ge neric drugs has to consider whether pa tients know what the term "ge neric" means. In a phar macy-based study in the Chi cago area, nearly all re spon dents were fa mil iar with this term [Pedulka et al 1989]. The rate in our study was 63%.…”

Section: Strengths and Limitationssupporting

confidence: 44%

“…In ad di tion to pre vi ous stud ies [Avery et al 2000, Pedulka et al 1989], we com pared pa tient at ti tudes to wards drugs with the (perceived) qual ity of the doc tor's in for ma tion on ge neric drugs and sub sti tu tion. Al though this study in cluded more prac tices and more patients than pre vi ous sur veys, a sam pling bias may have oc curred.…”

Section: Strengths and Limitationsmentioning

confidence: 99%

“…From an eco nomic point of view, par tic u larly in chronic pa tients, a sub sti tution is likely to have a re mark able ef fect in cost sav ing -at least for the stat u tory health in sur an ces. From a pri mary care point of view, it will be more dif fi cult for doc tors to per suade these pa tients to ac cept a ge neric sub sti tu tion with out first talk ing to them about their aver sion of tak ing generics for their dis or der [Pedulka et al 1989]. The same will be true in older pa tients and in those who reg u larly take sev eral drugs.…”

Section: Implications Of Findingsmentioning

confidence: 99%

See 2 more Smart Citations

What do primary care patients think about generic drugs?

Himmel

Simmenroth-Nayda²,

Niebling³

et al. 2005

144

129

View full text Add to dashboard Cite

What do pri mary care pa tients think about ge neric drugs? Ab stract. Ob jec tive: To ex am ine the at titude of pa tients to wards ge neric drugs and pre scriptions con tain ing ge neric drugs as an al ter na tive to brand-name prod ucts, with a spe cial fo cus on in for ma tion on pa tients at titude to ge neric drugs pro vided by their general prac ti tio ners (GPs). Meth ods: A to tal of 804 pa tients in 31 gen eral prac tices were surveyed us ing a self-ques tion naire. The in fluence of age, sex, ed u ca tion, dis ease, knowledge of ge neric drugs, ex pe ri ence with generic sub sti tu tion and in for ma tion pro vided by the GP on pa tient at ti tudes to wards ge neric drugs and sub sti tu tions were ex am ined. Results: Nearly two thirds of the pa tients (509/804) stated that they knew of the dif ference be tween brand-name drugs and generics; of these, one third were not sat is fied with the in for ma tion given by their GPs and 37% of pa tients ex pressed gen eral skep ti cism to wards ge neric drugs be cause of their lower price. This at ti tude was more fre quent among those who felt that ge neric pre scrib ing was "in vented" to solve the fi nan cial cri sis in the Ger man health in sur ance sys tem at their expense (odds ra tio (OR): 6.2; 95% con fi dence in ter val: 4.0-9.8) and those who had not been con fronted per son ally with a ge neric sub sti tu tion (OR: 1.8; 1.3-3.0). Pa tients who had been skep ti cal when first con fronted with a ge neric sub sti tu tion were more fre quently among those who con sid ered in ex pen sive drugs to be in fe rior (OR: 4.5; 2.0-10.4) and they were fre quently not sat is fied with the infor ma tion on sub sti tu tion pro vided by their GP (OR: 2.7; 1.2-5.9). Con clu sion: GPs are in an ideal po si tion to in form their pa tients ade quately about the equiv a lence of brandname and ge neric drugs. How ever, the pa tient view that in ex pen sive drugs must be in fe rior may be dif fi cult to rec tify in the short term. Key words ge neric drugs-prescriptions-cost-ef fec tive ness-in for ma tion on drug ther apy-fam ily prac tice Re ceived De cem ber 8, 2004; ac cepted

show abstract

Section: Strengths and Limitationssupporting

confidence: 44%

Section: Strengths and Limitationsmentioning

confidence: 99%

Section: Implications Of Findingsmentioning

confidence: 99%

See 1 more Smart Citation

What do primary care patients think about generic drugs?

Himmel

Simmenroth-Nayda²,

Niebling³

et al. 2005

144

129

View full text Add to dashboard Cite

show abstract

“…This was evident by the study conducted by Podulka et al. 12 on 100 consumers in the USA; this study had found that generic medicines were perceived to be same as branded medicines in terms of quality. Respondents feel safe and confident if a physician or a pharmacist recommended generic medicines.…”

Section: Literature Reviewmentioning

confidence: 91%

Evaluating patients' perception towards generic and branded medicines: A segmentation approach

Alam

Mittal

Chawla

2017

Journal of Generic Medicines

View full text Add to dashboard Cite

The objective of this study is to identify the underlying subgroups of consumers in terms of their perceptions towards branded and generic medicines in emerging economies. To the best of our knowledge, no research till date has dwelled on their patient segmentation based on their psychographic towards medicine. This makes the current study a seminal attempt in its category. Based on the survey data collected by the authors from Delhi and National Capital region of India, the present research employs consumer research methodologies. Cluster analysis based on psychographics and demographic was employed to cluster consumers based on their perception towards and generic medicines. The cluster-based analysis segmented the patients into three categories namely Branded Medicine Inclined, Generic Medicine inclined, Cost Conscious. From the extant review of the literature, it was observed that segmentation of patients based on their perceptions was found to be insignificant. Identifying and establishing patient clusters will help the government agencies in devising and managing healthcare awareness program towards generic medicines in an efficient fashion.

show abstract

“…15 Other studies have shown that for patients with chronic diseases, generic substitutes are less likely to be prescribed because patients are less likely to want to use generic drugs when treating chronic diseases. 16,17 Drug product characteristics, pharmaceutical reimbursement system, policy environment, consumers' socioeconomic characteristics, contact with health care professionals, experience with medications, knowledge of the seriousness of a medical condition, and even a consumer's need to project positive self-attributes have also all been shown to impact a consumer's view towards generic medications. 12,18 THE PAYER Key points d Third-party payers can encourage generic drug use by mandating generic substitution when available and by charging higher copayments for brand name drugs…”

Section: The Pharmacistmentioning

confidence: 97%

Generic drugs in dermatology

Payette

Grant‐Kels

2012

Journal of the American Academy of Dermatology

View full text Add to dashboard Cite

In part I, we discussed new drug development, reviewed the history of the generic drug industry, described how generic drugs are approved by the US Food and Drug Administration, and defined the concepts of bioequivalence and therapeutic equivalence. Herein, we explore various factors impacting generic drug use across the different parties involved: the prescriber, the pharmacist, the patient, and the payer. We also include original cost analysis of dermatologic brand name and generic drugs and show the potential cost savings that can be achieved through generic substitution. We conclude with a review of the data addressing potential differences in the effectiveness of brand name versus generic drugs in dermatology. The cost of brand name and generic medications is highly variable by pharmacy, state, and payer. We used one source (www.drugstore.com) as an example and for consistency across all medications discussed herein. Prices included here may not reflect actual retail prices across the United States.

show abstract

Consumers' Attitudes Toward Generic Drugs

Cited by 14 publications

References 2 publications

What do primary care patients think about generic drugs?

What do primary care patients think about generic drugs?

Evaluating patients' perception towards generic and branded medicines: A segmentation approach

Generic drugs in dermatology

Contact Info

Product

Resources

About